Recent studies have confirmed that HPV vaccine prevents cervical cancer, which, according to the World Health Organization, is the second most common type of cancer in women worldwide. Since this illness causes 500,000 new cases and 250,000 deaths per year, it is important to grasp how HPV vaccine can diminish the rates. Doctor Jeffrey Klausner, professor of medicine at Ronald Reagan UCLA Medical Center stated that people in the United States do not get vaccinated against cervical cancer, but countries like Rwanda have a vaccination rate of 97 percent.
The United States Centers for Disease Control and Prevention concluded that approximately 15,000 cancers have HPV as a cause on a yearly basis, and the one which attacks the cervix is the most common. However, only 7,000 cancers caused by the virus occur in men and the most ordinary is throat cancer. Doctor Subhakar Mutyala, associate director of Scott and White Cancer Institute at Texas College of Medicine stated that approximately one-third of girls in the United States are vaccinated, although it has been proved that HPV vaccine prevents cervical cancer.
A report published in the journal Cancer Prevention Research shows that one dose of HPV vaccine is enough to prevent the type of cancer which affects the cervix, which may mean that more people could accept to be vaccinated, thanks to the lower costs and simpler delivery.
The HPV vaccine is recommended to both girls and boys before they begin their sex life, and although the number of vaccinated people is currently low, it could increase since vaccine administration will become more available. One study in Costa Rica aims at showing that HPV vaccine can prevent cervical cancer, and its findings are promising. According to the results, women who accepted the vaccine have antibodies which work against the virus and can persist for four years.
A study carried out in Queensland, Australian also confirmed that HPV vaccine prevents cervical cancer, vaginal and vulvar lesions, but also genital warts which also lead to this certain type of cancer.
Australia was also the first nation to create vaccine program using public funds and the vaccination spree began in 2007. Since then, over 100,000 also received the pap test, which seeks precancerous and cancerous lesions on the cervix. Doctor Klausner concluded that the study compared women with cervical conditions and those without, and reported an approximately 50 percent diminish in risk in women vaccinated. At the same time, Doctor Mutyala stated that Australia’s aim is to eradicate the HPV virus, therefore the cervical cancer.
Danish research published similar findings, namely that young women who accepted to received HPV vaccination had a lower risk for precancerous lesions when compared to those who were not vaccinated.
Unfortunately, doctors concluded that the United States does not have a high rate of people who accept the vaccine, irrespective of gender. It has been estimated that approximately one-third of girls and about seven percent of boys are currently vaccinated. Irrespective of the low number of HPV vaccine in the United States, several studies have proved that it can prevent cervical cancer.
By Gabriela Motroc
The Information Daily